BOSTON, March 17, 2011 /PRNewswire/ — Experts from PAREXEL
International Corporation (Nasdaq:
PRXL), a leading global biopharmaceutical services provider,
will address best-practice strategic partnership models to increase
operating efficiency and improve development effectiveness during
the 20th Annual Partnerships in Clinical Trials conference, to be
held March 30-April 1, 2011 in Phoenix, Arizona. Attendees can
learn more about how PAREXEL has transformed its
business to deliver a new level of
strategic partnering, based on program design expertise,
operational excellence, and project leadership to help clients
achieve their development goals by visiting PAREXEL Booth
#707 in the exhibit hall.
In two special presentations with Merck and Bristol-Myers
Squibb, PAREXEL will discuss leveraging global resources and a
worldwide technology infrastructure, as well as innovative
approaches, to achieve significant value creation through strategic
relationships:
eClinical Technology Track, March 31, 2:15 p.m.
The Evolution of CROs—Convergence of Service and
Technology Providers will be presented by Mark A. Goldberg,
M.D., Chief Operating Officer, PAREXEL with Lynne Germscheid,
Account Management, Clinical and Regulatory Operations, Merck
Research Laboratories Information Technology.
Strategic Sourcing Track, April 1, 11:00 a.m.
Committing to Two Partners—A Look at the BMS Integrated
Strategic Sourcing Initiative will feature Joshua Schultz,
Corporate Vice President and Strategic Account Leader, PAREXEL with
Joan Millsaps, Director, Business Operations and Outsourcing
Management and Cynthia Hauck, Associate Director, Outsourcing
Management of Bristol-Myers Squibb.
The Partnerships in Clinical Trials pr
‘/>”/>
